Molecular and physiological evidence for multifunctionality of carnitine/organic cation transporter OCTN2

Molecular Pharmacology

Volumn 59, Issue 2, 2001, Pages 358-366

  Ohashi, Rikiya ^a   Tamai, Ikumi ^a,b   Nezu, Jun Ichi ^c   Nikaido, Hiroko ^a   Hashimoto, Noriyoshi ^a   Oku, Asuka ^c   Sai, Yoshimichi ^a,b   Shimane, Miyuki ^c   Tsuji, Akira ^a,b  

^a KANAZAWA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; ORGANIC CATION TRANSPORTER 2; TETRYLAMMONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARNITINE DEFICIENCY; CATION TRANSPORT; CONTROLLED STUDY; FEMALE; FIBROBLAST; KIDNEY CLEARANCE; KIDNEY TUBULE EXCRETION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEATOSIS; TISSUE DISTRIBUTION;

EID: 0035132434     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.2.358     Document Type: Article

References (41)

1. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
2. Pharmacokinetics of cephalosporin antibiotics
3. +L-like. A tertiary active transport mechanism for renal reabsorption of cystine and dibasic amino acids
4. Gene-dose effect on carnitine transport activity in embryonic fibroblasts of jvs mice as a model of human carnitine transporter deficiency
5. Transport of organic anion in the OK kidney epithelial cell line
6. Primary defect of juvenile visceral steatosis (jvs) mouse with systemic carnitine deficiency is probably in renal carnitine transport system
7. Cardiac hypertrophy in juvenile visceral steatesis (jvs) mice with systemic carnitine deficiency
8. Intestinal secretion of drugs. The role of pglycoprotein and related drug efflux systems in limiting oral drug absorption
9. The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1
10. Effect of cephaloridine on the transport of organic ions in dog kidney plasma membrane vesicles
11. Molecular pharmacology of organic cation transporters in kidney
12. Gene-dose effect on carnitine transport activity in embryonic fibroblasts of JVS mice as a model of human carnitine transporter deficiency
13. Serum levels and urine excretion of L-carnitine in patients with normal and impaired kidney function
14. A missense mutation of mouse OCTN2, a sodium-dependent carnitine cotransporter, in the juvenile visceral steatosis mouse
15. Tissue distribution kinetics of tetraethylammonium ion in the rat
16. Heterogeneity of histopathological features in the congenitally carnitine-deficient juvenile visceral steatosis (jvs) mouse
17. Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter
18. Pharmacokinetics and clinical use of cephalosporin antibiotics
19. +-dependent carnitine transport by organic cation transporter (OCTN2): Its pharmacological and toxicological relevance
20. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport
21. +L-type by heterodimers of 4F2hc/CD98 and members of the glycoprotein-associated amino acid transporter family
22. Mechanisms mediating renal secretion of organic anions and cations
23. Mutations in novel organic cation transporter (OCTN2), an organic cation/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function
24. The molecular biology of renal organic anion and organic cation transporters
25. Transport of cephalosporin antibiotics in rat renal basolateral membranes
26. Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2
27. Molecular and functional characterization of organic cation/carnitine transporter family in mice
28. Cloning and characterization of a novel human pH-dependent organic cation transporter OCTN1
29. Absorption, distribution and excretion of SCE-963, a new broad-spectrum cephalosporin, in mice, rats, rabbits and dogs
30. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man
31. Physiologically based pharmacokinetic model for beta-lactam antibiotics. I: Tissue distribution and elimination in rats
32. Faropenem transport across the renal epithelial luminal membrane via inorganic phosphate transporter NPT1
33. p-Aminohippuric acid transport at renal apical membrane mediated by human inorganic phosphate transporter NPT1
34. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter
35. cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family
36. Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations
37. Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: Renal clearance in rats and rabbits
38. Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice
39. Characteristics of L-carnitine transport in cultured human hepatoma HLF cells
40. Loss of wild-type carrier-mediated L-carnitine transport activity in hepatocytes of juvenile visceral steatosis mice
41. Role of organic cation transporters in drug absorption and elimination